Johns Hopkins Division of Infectious Diseases
@JHMed_ID
Followers
1K
Following
831
Media
205
Statuses
2K
We're committed to combating infectious diseases through research, patient care, prevention, and education.
Joined September 2019
Morning Read: The Role of Integrated HBV DNA in the Quest for a Cure in HIV/HBV co-infection
pubmed.ncbi.nlm.nih.gov
Functional cure of chronic hepatitis B infection is characterized by durable loss of hepatitis B surface antigen (HBsAg) from blood after treatment discontinuation. Because HBsAg is transcribed from...
0
0
1
Morning Read: A scoping review of equity toolkits for international academic partnerships https://t.co/0lcjwduAKV
pubmed.ncbi.nlm.nih.gov
There was variability in the development, intended audience, and application methods of the toolkits, yet there was also substantial thematic content overlap. Limited information on the application...
0
0
1
Looking for online, self-paced CME courses on infectious diseases? We've got you covered! https://t.co/nBJNrdza9J
0
0
0
Morning Read: Combinations comprising dual β-lactams and a β-lactamase inhibitor achieve optimal synergistic inhibition of Mycobacterium abscessus growth
pubmed.ncbi.nlm.nih.gov
The historical model, which posits that β-lactams inhibit bacterial growth while β-lactamase inhibitors (BLIs) merely protect β-lactams from enzymatic degradation, fails to fully explain their...
0
0
1
Morning Read: Exploration of imidazothiazole and imidazopyrimidine carboxamides for enhanced antitubercular activity https://t.co/uto1OLKh87
pubmed.ncbi.nlm.nih.gov
Tuberculosis (TB) is an insidious disease that has been around for many centuries. The advent of multidrug-resistant strains of TB has caused a significant setback in eradicating this disease; most...
0
0
1
Join us on Thursday, November 6 for Bridging Perspectives in COVID's Wake. This event will bring together public health, science, and policy experts to discuss lessons that can strengthen our response to future public health challenges. Registration is free and a video
hub.jhu.edu
Scholars and experts examine how scientific evidence, policy implementation, and public communication intersected during the COVID-19 pandemic, with the aim of identifying lessons that can strengthen...
1
5
4
ID in the News: Dr. Sean Anderson discusses C diff research presented at IDWeek 2025: "Leveraging knowledge of [C diff] colonization status into clinical decision-making is a significant gray area in practice currently, even for experts in the field..." https://t.co/N3xpcKPQka
0
0
1
I loved how all the different services came together to present today’s fascinating case at the @OslerResidency grand rounds. Such an impressive multidisciplinary discussion!
0
5
33
Congratulations to our ACGME Adult Infectious Diseases Fellowship Program Director, Dr. Michael Melia, honored by @IDSAInfo with the society’s Clinical Teacher Award! @MikeMeliaMD
https://t.co/2uK6V6hgOp
0
1
2
ID in the News: @geeta_sood1 notes: " 'there’s not a lot of hard science' suggesting that what you eat while you’re sick — whether with a cold or something worse — will make much of a difference in your recovery."
nytimes.com
We asked experts if the adage is true.
0
0
1
Morning Read: One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis https://t.co/g1A5SAvvBT
pubmed.ncbi.nlm.nih.gov
Treatment with one dose of 2.4 million units of benzathine penicillin G was noninferior to treatment with three doses with regard to serologic response 6 months after treatment. (Funded by the...
0
0
0
Congratulations to Dr. Cynthia Sears, honored with @IDSAInfo 2025 Alexander Fleming Lifetime Achievement Award! 👏👏👏
Congratulations to Cynthia Sears, MD, FIDSA, recipient of IDSA’s 2025 Alexander Fleming Award for Lifetime Achievement! 🎉 Her groundbreaking research, leadership & mentorship have advanced understanding of the microbiota’s role in colorectal cancer: https://t.co/Df1tysiQFO
0
0
3
Morning Read: A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial https://t.co/XK5J8w2L30
pubmed.ncbi.nlm.nih.gov
US National Institutes of Health Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) and the National Institute of Allergy and Infectious Diseases.
0
0
2
ID in the News: @MorganKatz4 dicusses signs of infection among older adults: “We see very atypical presentations for some of these respiratory viruses in older adults" ...
aarp.org
Don’t overlook these unusual symptoms as flu season approaches
0
0
0
Morning Read: The Access Partnership: Expanding Outpatient Health Care Access for Uninsured Patients at One Academic Medical Center https://t.co/qLy4sNOhk1
pubmed.ncbi.nlm.nih.gov
TAP-FA is an innovative charity care model operationalizing a financial assistance policy for individuals with financial need who are ineligible for subsidized insurance. In the absence of federal...
0
0
1
Morning Read: Cholesterol efflux in HIV-associated atherosclerosis: mechanisms and targets https://t.co/KeFcr4LrQd
pubmed.ncbi.nlm.nih.gov
Antiretroviral therapy (ART) has transformed HIV infection into a chronic, manageable condition; however, people living with HIV (PLWH) have an increased risk of atherosclerotic cardiovascular...
0
0
0
Morning Read: HIV index testing implementation at public health clinics in South Africa https://t.co/ZeflrCUvTv
0
0
0
Check out Viremic -- Cases in HIV, a biweekly Apple podcast hosted by Drs. Eileen Scully & Christopher Hoffmann, which explores quandaries in adult HIV care. ***For informational purposes only & not offered as practice advice for patients or clinicians. https://t.co/qFUu6TOnjA
podcasts.apple.com
Medicine Podcast · Updated Biweekly · Hosted by Eileen Scully, MD, PhD, and Christopher Hoffmann, MD, MSC, MPH, both HIV specialists at Johns Hopkins, Viremic explores quandaries in adult HIV care....
0
0
2
Morning Read: Addressing Health Disparities Associated with the HIV PrEP Initiation Cascade, Baltimore City Health Department Sexual Health Clinics, 2016-2023 https://t.co/gaULbCjeAb
pubmed.ncbi.nlm.nih.gov
Expansion of access to PrEP and usage of 'priority patient' criteria for PrEP initiation, along with direct feedback to clinicians, was associated with decreased disparities in 1) PrEP discussions...
0
1
2